THURSDAY, Feb. 27, 2014 (HealthDay News) -- There's early
evidence from a small study that people with amyotrophic lateral
sclerosis -- also known as ALS or Lou Gehrig's disease -- who are
fed a high-calorie, high-carb diet, may see the progression of
their disease slowed.
ALS is a degenerative disease that kills nerve cells, leading to
weakness, paralysis and usually death from respiratory failure. As
the disease progresses, patients often lose a significant amount of
Patients with ALS who have difficulty swallowing, as did the 24
in this study, often end up needing a feeding tube into the stomach
to get enough to eat. These patients are usually fed a standard
commercially available formula.
"Giving your patients more energy [calories] than they necessarily need or are burning could help them prevent disease progression, and it might actually help improve their survival," said lead researcher Dr. Anne-Marie Wills, an assistant professor of neurology at Harvard Medical School.
Wills explained that ALS patients lose weight in part because
they are not able to take in enough calories due to their
difficulty swallowing. "As they lose weight they are actually
burning their own muscle," she said.
In the study, researchers found that a high-calorie, high-carb
tube-fed diet was safe and tolerated -- better than one designed to
maintain weight or a diet high in fat, Wills said.
Moreover, patients on the high-calorie, high-carb diet gained
some of the weight they had lost, she said.
At the very least, patients should avoid losing weight, Wills
added. "We need larger trials to see if patients should be trying
to gain weight, but until that happens, I think all ALS patients
should try aggressively to avoid weight loss," she said.
The report was published in the Feb. 28 online edition of
Several experts noted that the results are far from
Dr. Ammar Al-Chalabi, a professor of neurology and complex
disease genetics at King's College London, and author of an
accompanying journal editorial, said, "This study is too small to
really show a survival benefit of any of the diets."
To really know if there is a benefit, a larger trial is needed,
but such a study is fraught with problems, Al-Chalabi said. One
concern is that given the results of this preliminary study,
patients may decide to try a high-calorie, high-carbohydrate diet
on their own.
"Anyone with ALS will do a simple cost-benefit analysis: 'What is the cost to changing my diet? -- almost nothing. What is the benefit? -- possibly a better outcome,' " he said. "We may never know if these diets really work, what the diet change should be, and when it should be changed, if at all," Al-Chalabi said.
Dr. Zianka Fallil, a neurologist at the Cushing Neuroscience
Institute in Manhasset, N.Y., agreed that the study was too small
to make conclusions.
"The study would be more credible if it had more patients," she said.
For the study, Wills and colleagues recruited 24 ALS patients
who had lost a lot of weight and were being fed through a tube
placed directly into the stomach.
Patients were assigned to one of three groups. One group was fed
enough to maintain their current weight, a second group was fed a
formula high in fat, and the third group a formula high in carbs.
Both of the latter groups were fed more calories than needed to
maintain their weight.
The high-carb, high-calorie diet consisted of a commercial
tube-feeding formula called Jevity 1.5, which contains 150 percent
of the calories needed to maintain weight, Wills said. The high-fat
diet consisted of a formula called Oxepa. Those on the
weight-maintenance diet were given Jevity 1.0.
Over four months, patients kept track of their weight as well as
how much they took in through their feeding tube and anything they
were able to eat by mouth. During that time, one patient on the
high-fat diet and six in the weight-maintenance diet dropped out of
the study. But none of those on the high-carbohydrate diet did
The researchers found that patients on the high-carbohydrate
formula gained a modest amount of weight, patients on the high-fat
diet lost weight and the others maintained their weight.
Over five months of follow-up, none of the patients on the
high-carbohydrate diet died. One in the high-fat group and three in
the weight maintenance group died. All the deaths were from
Those on the high-carbohydrate diet also saw a slowing of the
progression of the disease compared to the weight-maintenance
group, although the difference was not significant, the researchers
Nina Eng, chief clinical dietitian at Plainview Hospital, in New
York, explained that standard equations are used to figure out how
much to feed an ALS patient based on energy needs.
"I wouldn't take this study and start feeding all patients with ALS a high-calorie diet -- you need more information," she said. "We don't know if it's helpful to give every patient with ALS a high-calorie, high-carbohydrate diet. Common practice is to use these equations to meet their needs."
To learn more about ALS, visit the
U.S. National Institute of Neurological Disorders and
EBSCO Information Services is fully accredited by URAC. URAC is an independent, nonprofit health care accrediting organization dedicated to promoting health care quality through accreditation, certification and commendation.
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.
Copyright © EBSCO Information Services. All rights reserved.